The Patent Finder

Terms ending in 2027

Abraxis Bioscience, LLC

Every in-force patent on Abraxis Bioscience, LLC's record whose computed term ends in 2027, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 8,026,275Compositions, Methods of Use and Preparation of 2,6-Diisopropyl Phenol and Analogs for Ischemic Injury
In force
 · High confidence
Nantbioscience, Inc.In forceHigh confidence
US 8,735,394Combinations and Modes of Administration of Therapeutic Agents and Combination Therapy
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 7,858,782Triazine Derivatives and Their Therapeutical Applications
In force
 · High confidence
Nantbioscience, Inc.In forceHigh confidence
US 8,999,396Breast Cancer Therapy Based on Hormone Receptor Status with Nanoparticles Comprising Taxane
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 9,675,578Breast Cancer Therapy Based on Hormone Receptor Status with Nanoparticles Comprising Taxane
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 9,724,323Breast Cancer Therapy Based on Hormone Receptor Status with Nanoparticles Comprising Taxane
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
US 10,682,420Breast Cancer Therapy Based on Hormone Receptor Status with Nanoparticles Comprising Taxane
In force
 · High confidence
Abraxis Bioscience, LLCIn forceHigh confidence
7 of 7 patents shown. Soonest term end first, then patent number.
5 of these are in force and held by Abraxis Bioscience, LLC.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited